- Report
- July 2024
- 120 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- February 2024
- 130 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- February 2024
- 115 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- April 2023
- 120 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- April 2023
- 113 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- August 2022
- 115 Pages
Global
From €4175EUR$4,750USD£3,611GBP
- Report
- April 2024
- 134 Pages
Global
From €2778EUR$3,160USD£2,403GBP
€3472EUR$3,950USD£3,003GBP
- Report
- January 2024
- 140 Pages
Global
From €2989EUR$3,400USD£2,585GBP
€3736EUR$4,250USD£3,231GBP
- Report
- September 2023
- 143 Pages
Global
From €3129EUR$3,560USD£2,707GBP
€3911EUR$4,450USD£3,383GBP
- Report
- July 2024
- 166 Pages
Global
From €2197EUR$2,500USD£1,901GBP
- Report
- May 2024
- 176 Pages
Global
From €2197EUR$2,500USD£1,901GBP
- Report
- October 2023
- 172 Pages
Global
From €2197EUR$2,500USD£1,901GBP
- Report
- March 2024
- 143 Pages
Global
From €3164EUR$3,600USD£2,737GBP
- Report
- March 2024
- 97 Pages
Asia Pacific
From €1318EUR$1,500USD£1,140GBP
- Report
- March 2024
- 97 Pages
Africa, Middle East
From €1318EUR$1,500USD£1,140GBP
- Report
- May 2023
- 236 Pages
Global
From €3164EUR$3,600USD£2,737GBP
- Report
- May 2023
- 89 Pages
Middle East, Africa
From €1318EUR$1,500USD£1,140GBP
- Report
- May 2023
- 89 Pages
Asia Pacific
From €1318EUR$1,500USD£1,140GBP
- Report
- May 2023
- 89 Pages
Europe
From €1318EUR$1,500USD£1,140GBP
- Report
- May 2023
- 77 Pages
North America
From €1318EUR$1,500USD£1,140GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more